psychedelics investing Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference
psychedelics investing Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights
psychedelics investing Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities
psychedelics investing Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
psychedelics investing Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
psychedelics investing Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
Finlay Minerals: Advancing Strategic Copper-Gold-Silver Assets in British Columbia’s Toodoggone District
Sun Summit Commences 2025 Exploration Program at the JD Project, Toodoggone District, British Columbia
